# Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

> **NCT00795613** · PHASE2 · UNKNOWN · sponsor: **Ospedale Santa Croce-Carle Cuneo** · enrollment: 450 (estimated)

## Conditions studied

- HODGKIN LYMPHOMA

## Interventions

- **DRUG:** ESCALATED BEACOPP
- **DRUG:** CONVENTIONAL ABVD

## Key facts

- **NCT ID:** NCT00795613
- **Lead sponsor:** Ospedale Santa Croce-Carle Cuneo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2014-11
- **Final completion:** 2015-10
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2015-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795613, "Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00795613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*